Dengue Virus
Rory M. Marks,
Rory M. Marks
- [email protected]
- 734-936-3257 | Fax: 734-763-2025
University of Michigan, Dept. Internal Medicine, Ann Arbor, Michigan, 48104
Search for more papers by this authorRory M. Marks,
Rory M. Marks
- [email protected]
- 734-936-3257 | Fax: 734-763-2025
University of Michigan, Dept. Internal Medicine, Ann Arbor, Michigan, 48104
Search for more papers by this authorFirst published: 15 October 2002
No abstract is available for this article.
References
- 1 Rice, C.M., Flaviviridae: the viruses and their replication, in Fields Virology 3rd edition, B.N. Fields, D.M. Knipe, and P.M. Howley, Editors. 1996, Lippincott-Raven: Philadelphia. p. 931–959.
- 2 Ashburn, P.M. and C.F. Craig, Experimental investigations regarding the etiology of dengue fever. Journal of Infectious Diseases, 1907. 4: p. 440–475.
- 3 Monath, T.P. and F.X. Heinz, Flaviviruses, in Fields Virology 3rd edition, B.N. Fields, D.M. Knipe, and P.M. Howley, Editors. 1996, Lippincott-Raven: Philadelphia. p. 961–1034.
- 4 Howard, C.R., Viral hemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Research, 1984. 4: p. 169–186.
- 5 Bancroft, T.L., On the aetiology of dengue fever. Australian Medical Gazette, 1906. 25: p. 17–18.
- 6 Siler, J.F., H. M.W., and A.P. Hitchens, Dengue: Its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity, and prevention. The Phillipine Journal of Science, 1926. 29(1–2): p. 1–304.
- 7 T.P. Monath, ed. The arboviruses: ecology and epidemiology. 1988, CRC Press: Boca Raton, Florida.
- 8 Halstead, S.B., Pathogenesis of dengue: challenges to molecular biology. Science, 1988. 239: p. 476–481.
- 9 Halstead, S.B., The XXth century dengue pandemic: need for surveillance and research. World Health Stat Q, 1992. 45(2–3): p. 292–298.
- 10 World Health Organization, Dengue and dengue hemorrhagic fever. Report N117. 1996, World Health Organization.
- 11 Sharp, T.W., et al., Dengue fever in U.S. troops during operation restore hope, Somalia, 1992–1993. Am. J. Trop. Med. Hyg., 1995. 53(1): p. 89–94.
- 12 Monath, T.P., Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci (USA), 1994. 91: p. 2395–2400.
- 13 Meltzer, M.I. and G. D.J., Assessing the global economic impact of dengue and DHF. Amer J Trop Med Hyg, 1998. 59(3): p. 157.
- 14 Meltzer, M.I., et al., Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. Am. J. Trop. Med. Hyg., 1998. 59(2): p. 265–271.
- 15 Rigau-Perez, R., The emergence of dengue hemorrhagic fever as a threat to public health in Puerto Rico. Amer J Trop Med Hyg, 1996. 55(2): p. 50.
- 16 Innis, B.L., Dengue and dengue hemorrhagic fever, in Exotic viral infections, J.S. Porterfield, Editor. 1995, Chapman & Hall: London. p. 103–146.
- 17 Clark, G., Public-private partnerships to develop and implement community-based prevention programs. Amer J Trop Med Hyg, 1996. 55(2): p. 50.
- 18 Henchal, E.A. and J.R. Putnak, The dengue viruses. Clinical Microbiology Reviews, 1990. 3: p. 376–396.
- 19 Simmons, J.S., J.H. St. John, and F.H.K. Reynolds, Experimental studies of dengue. The Phillipine Journal of Science, 1931. 44(1–22): p. 1–252.
- 20 Quintos, F.N., et al., Hemorrhagic fever observed among children in the Philippines. Philippine Journal of Pediatrics, 1954. 3: p. 1–9.
- 21 Jatanasen, S., P. Sakuntanaga, and C. Dhanasiri. Some aspects of epidemiology of Thai hemorrhagic fever, 1958–1961. in Thai Hemorrhagic Fever Symposium. 1961. Bangkok, Thailand: SEATO Medical Research Monograph.
- 22 Hammon, W.M., A. Rudnick, and G.E. Sather, Viruses associated with hemorrhagic fever of the Philippines and Thailand. Science, 1960. 131: p. 1102–1103.
- 23 Technical-Advisory-Committee, Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. 1986, World Health Organization: Geneva.
- 24 World-Health-Organisation, WHO Technical Guides for Diagnosis, Treatment,Surveillance, Prevention and Control of Dengue Haemorrhagic Fever. 1975, World Health Organisation: Geneva.
- 25 Bhamarapravati, N., P. Tuchinda, and V. Boonyapaknavik, Pathology of Thailand hemorrhagic fever: a study of 100 autopsy cases. Am. J. Trop. Med. Parasitol, 1967. 61: p. 500–510.
- 26 Innis, B.L., et al., Acute liver failure is one important cause of fatal dengue infection. South East Asian Journal of Tropical Medicine and Public Health, 1990. 21: p. 695–696.
- 27 Rosen, L., M.T. Drouet, and V. Deubel, Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. American Journal of Tropical Medicine & Hygiene, 1999. 61(5): p. 720–724.
- 28 Halstead, S.B., S. Nimmannitya, and M.R. Margiotta, Dengue and chikungunya virus infection in man in Thailand, 1962–1964. II. Observations on disease in outpatients. American Journal of Tropical Medicine & Hygiene, 1969. 18(6): p. 972–983.
- 29 Halstead, S.B., et al., Dengue chikungunya virus infection in man in Thailand, 1962–1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. American Journal of Tropical Medicine & Hygiene, 1969. 18(6): p. 984–96.
- 30 Halstead, S.B., et al., Dengue and chikungunya virus infection in man in Thailand, 1962–1964. IV. Epidemiologic studies in the Bangkok metropolitan area. American Journal of Tropical Medicine & Hygiene, 1969. 18(6): p. 997–1021.
- 31 Halstead, S.B., et al., Dengue and chikungunya virus infection in man in Thailand, 1962–1964. V. Epidemiologic observations outside Bangkok. American Journal of Tropical Medicine & Hygiene, 1969. 18(6): p. 1022–33.
- 32 Halstead, S.B., Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale Journal of Biology & Medicine, 1970. 42(5): p. 350–62.
- 33 Halstead, S.B., S. Nimmannitya, and S.N. Cohen, Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale Journal of Biology & Medicine, 1970. 42(5): p. 311–28.
- 34 Halstead, S.B., et al., Observations related to pathogenesis of dengue hemorrhagic fever. I. Experience with classification of dengue viruses. Yale Journal of Biology & Medicine, 1970. 42(5): p. 261–75.
- 35 Nimmannitya, S., et al., Dengue and chikungunya virus infection in man in Thailand, 1962–1964. I. Observations on hospitalized patients with hemorrhagic fever. American Journal of Tropical Medicine & Hygiene, 1969. 18(6): p. 954–71.
- 36 Nisalak, A., et al., Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. Yale Journal of Biology & Medicine, 1970. 42(5): p. 293–310.
- 37 Porterfield, J.S., Antibody-dependent enhancement of viral infectivity. Adv. Virus. Research, 1986. 31: p. 335–355.
- 38 Halstead, S.B., Antibody-dependent enhancement of infection: a mechanism for indirect virus entry into cells, in Cellular receptors for animal viruses, E. Wimmer, Editor. 1994, Cold Spring Harbor Laboratory Press: New York. p. 493–516.
- 39 Harris, E., et al., Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. American Journal of Tropical Medicine & Hygiene, 2000. 63: p. 5–11.
- 40 Vaughn, D.W., et al., Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. Journal of Infectious Diseases, 2000. 181(1): p. 2–9.
- 41
Schlesinger, R.W.,
Dengue viruses.
1977,
New York:
Springer-Verlag.
10.1007/978-3-7091-8466-0 Google Scholar
- 42 Halstead, S.B., H. Shotwell, and J. Casals, Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. Journal of Infectious Diseases, 1973. 128(1): p. 15–22.
- 43 Marchette, N., et al., Studies on the pathogenesis of dengue infection in monkeys. III. Sequential distribution of virus in primary and heterologous infection. J Inf Dis, 1973. 128(1): p. 23–30.
- 44 Halstead, S., H. Shotwell, and J. Casals, Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Inf Dis, 1973. 128(1): p. 7–14.
- 45 Wu, S.-J.L., et al., Human skin Langerhans cells are targets of dengue virus infection. Nature Medicine, 2000. 6: p. 816–820.
- 46 Klagge, I.M. and S. Schneider-Schaulies, Virus interactions with dendritic cells. Journal of General Virology, 1999. 80: p. 823–833.
- 47 Banchereau, J., et al., Immunobiology of dendritic cells. Annual Review of Immunology, 2000. 18: p. 767–811.
- 48 MacPherson, G., N. Kushnir, and M. Wykes, Dendritic cells, B cells and the regulation of antibody synthesis. Immunological Reviews, 1999. 172: p. 325–334.
- 49 Scott, R.M., et al., Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. Journal of Infectious Diseases, 1980. 141(1): p. 1–6.
- 50 King, A.D., et al., B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian Journal of Tropical Medicine & Public Health, 1999. 30(4): p. 718–28.
- 51 Sumarmo, S.P., et al., Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bulletin of the WHO, 1983. 61: p. 692–701.
- 52 Dinarello, C.A., Cytokines as endogenous pyrogens. Journal of Infectious Diseases, 1999. 179(S2): p. S294–304.
- 53 Hober, D., et al., Serum levels of tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-1ß (IL-1ß) in dengue-infected patients. Am J Trop Med Hyg, 1993. 48(3): p. 324–331.
- 54 Leitmeyer, K.C., et al., Dengue Virus Structural Differences That Correlate with Pathogenesis. J. Virol, 1999. 73: p. 4738–4747.
- 55 Boonpucknavig, S., et al., Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch. Pathol. Lab. Med, 1979. 103: p. 463–466.
- 56 Goldblum, S.E., et al., Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infection & Immunity., 1989. 57(4): p. 1218–26.
- 57 Goldblum, S.E., et al., Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta. Infection & Immunity, 1988. 56(9): p. 2255–63.
- 58 Stephens, K.E., et al., Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. American Review of Respiratory Disease, 1988. 137(6): p. 1364–70.
- 59 Baluna, R. and E.S. Vitetta, Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology, 1997. 37(2–3): p. 117–32.
- 60 Kurane, I. and F.A. Ennis, Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Seminars in Virology, 1994. 5: p. 443–8.
- 61 Tyler, K.L. and B.N. Fields, Pathogenesis of viral infections, in Fields Virology 3rd edition, B.N. Fields, D.M. Knipe, and P.M. Howley, Editors. 1996, Lippincott-Raven: Philadelphia. p. 173–217.
- 62 He, R.-T., et al., Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J. Med. Virol., 1995. 45: p. 451–461.
- 63 Chen, Y., et al., Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Medicine, 1997. 3: p. 866–871.
- 64 Rostand, K.S. and J.D. Esko, Microbial adherence and invasion through proteoglycans. Infection and Immunity, 1997. 65: p. 1–8.
- 65 Ramos-Castaneda, J., et al., A 65-kDa trypsin-sensitive membrane cell protein as a possible receptor for dengue virus in cultured neuroblastoma cells. Journal of Neurovirology, 1997. 3(6): p. 435–440.
- 66 Salas-Benito, J.S. and R.M. delAngel, Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. Journal of Virology, 1997. 71(10): p. 7246–7252.
- 67
Halstead, S.B.,
Immunological parameters of togavirus disease syndromes, in
The togaviruses,
R. Sclessinger, Editor.
1980,
Academic Press:
New York.
p. 107–173.
10.1016/B978-0-12-625380-1.50010-2 Google Scholar
- 68 Churdboonchart, V., et al., Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. American Journal of Tropical Medicine & Hygiene, 1991. 44(5): p. 481–93.
- 69 Jacobs, M.G., et al., Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB Journal, 2000. 14(11): p. 1603–1610.
- 70 Kurane, I. and F.E. Ennis, Immunity and immunopathology in dengue virus infections. Seminars in Immunology, 1992. 4: p. 121–127.
- 71 Rothman, A.L., I. Kurane, and F.A. Ennis, Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus. Journal of Virology, 1996. 70(10): p. 6540–6546.
- 72 Kurane, I., et al., Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Archives of Virology - Supplementum, 1994. 9: p. 59–64.
- 73 Medzhitov, R. and C.A.J. Janeway, Innate immunity: the virtues of a nonclonal system of recognition. Cell, 1997. 91(3): p. 295–8.
- 74 Gura, T., Innate immunity. Ancient system gets new respect. Science, 2001. 291(5511): p. 2068–71.
- 75 Johnson, A.J. and J.T. Roehrig, New mouse model for dengue virus vaccine testing. Journal of Virology, 1999. 73(1): p. 783–786.
- 76 Diamond, M.S., et al., Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J. Virology, 2000. 74(11): p. 4957–4966.
- 77 Markoff, L.J. and B.N. Falgout, The family flaviviridae and its diseases, in Exotic Viral Infections, J.S. Porterfield, Editor. 1995, Chapman & Hall: London. p. 47–66.
- 78 Stollar, V., Studies on the nature of dengue viruses. IV. The structural proteins of type 2 dengue virus. Virology, 1969. 39: p. 426–438.
- 79 Zhao, B.T., et al., Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J. Virology, 1987. 61(12): p. 4019–4022.
- 80 Heinz, F.X., et al., Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology, 1994. 198(1): p. 109–17.
- 81 Ferlenghi, I., et al., Molecular Organization of a Recombinant Subviral Particle from Tick-Borne Encephalitis Virus. Molecular Cell, 2001. 7: p. 593–602.
- 82 Lescar, J., et al., The Fusion Glycoprotein Shell of Semliki Forest Virus: An Icosahedral Assembly Primed for Fusogenic Activation at Endosomal pH. Cell, 2001. 105: p. 137–148.
- 83 Pletnev, S.V., et al., Locations of Carbohydrate Sites on Alphavirus Glycoproteins Show that E1 Forms an Icosahedral Scaffold. Cell, 2001. 105: p. 127–136.
- 84 Strauss, J.H. and E.G. Strauss, Virus Evolution: How Does an Enveloped Virus Make a Regular Structure? Cell, 2001. 105: p. 5–8.
- 85 Rey, F.A., et al., The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature, 1995. 375(6529): p. 291–8.
- 86 Anderson, R., A.D. King, and B.L. Innis, Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J. General. Virology, 1992. 73: p. 2155–2159.
- 87 Hase, T., P.L. Summers, and K.H. Eckels, Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch. Virol, 1989. 104: p. 129–143.
- 88 Stiasny, K., et al., Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne-encephalitis virus. J. Virology, 1996. 70(11): p. 8142–8147.
- 89 Wengler, G., G. Wengler, and H.J. Gross, Studies on virus specific nucleic acids synthesized in vertebrate and mosquito cells infected with flavivirus. Virology, 1978. 89: p. 423–437.
- 90 Cleaves, G.R. and D.T. Dubin, Methylation status of intracellular dengue type 2 40S RNA. Virology, 1979. 96: p. 159–165.
- 91 Zeng, L., B. Falgout, and L. Markoff, Identification of specific nucleotide sequences within the conserved 3′-SL in the dengue type 2 virus genome required for replication. J. Virology, 1998. 72(9): p. 7510–7522.
- 92 Li, H., et al., The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. Journal of Virology, 1999. 73(4): p. 3108–3116.
- 93 Murthy, H.M., S. Clum, and R. Padmanabhan, Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. Journal of Biological Chemistry, 1999. 274(9): p. 5573–5580.
- 94 Winkler, G., et al., Newly synthesized dengue-2 virus non-structural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology, 1989. 171: p. 302–305.
- 95 Yusof, R., et al., Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. Journal of Biological Chemistry, 2000. 275(14): p. 9963–9969.
- 96 Koonin, E.V., Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and lambda 2 protein of reovirus. Journal of General Virology, 1993. 74(4): p. 733–740.
- 97 Tan, B.H., et al., Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology, 1996. 216(2): p. 317–325.
